List of Tables
Table 1. Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Competitive Situation by Manufacturers in 2023
Table 4. Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug, Product Type & Application
Table 12. Global Key Manufacturers of Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales by Region (2019-2024) & (K Units)
Table 18. Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Market Share by Region (2019-2024)
Table 19. Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales by Region (2025-2030) & (K Units)
Table 20. Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Market Share by Region (2025-2030)
Table 21. Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Revenue Market Share by Region (2019-2024)
Table 23. Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Revenue Market Share by Region (2025-2030)
Table 25. North America Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales by Country (2019-2024) & (K Units)
Table 27. North America Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales by Country (2025-2030) & (K Units)
Table 28. North America Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales by Country (2019-2024) & (K Units)
Table 32. Europe Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales by Country (2025-2030) & (K Units)
Table 33. Europe Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales (K Units) by Type (2019-2024)
Table 51. Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales (K Units) by Type (2025-2030)
Table 52. Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Market Share by Type (2019-2024)
Table 53. Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Market Share by Type (2025-2030)
Table 54. Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Revenue Market Share by Type (2019-2024)
Table 57. Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Revenue Market Share by Type (2025-2030)
Table 58. Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Price (US$/Unit) by Type (2019-2024)
Table 59. Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Price (US$/Unit) by Type (2025-2030)
Table 60. Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales (K Units) by Application (2019-2024)
Table 61. Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales (K Units) by Application (2025-2030)
Table 62. Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Market Share by Application (2019-2024)
Table 63. Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Market Share by Application (2025-2030)
Table 64. Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Revenue Market Share by Application (2019-2024)
Table 67. Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Revenue Market Share by Application (2025-2030)
Table 68. Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Price (US$/Unit) by Application (2019-2024)
Table 69. Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Price (US$/Unit) by Application (2025-2030)
Table 70. Basilea Pharmaceutica Ltd Corporation Information
Table 71. Basilea Pharmaceutica Ltd Description and Business Overview
Table 72. Basilea Pharmaceutica Ltd Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Basilea Pharmaceutica Ltd Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Product
Table 74. Basilea Pharmaceutica Ltd Recent Developments/Updates
Table 75. The Medicines Company Corporation Information
Table 76. The Medicines Company Description and Business Overview
Table 77. The Medicines Company Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. The Medicines Company Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Product
Table 79. The Medicines Company Recent Developments/Updates
Table 80. Theravance Biopharma Corporation Information
Table 81. Theravance Biopharma Description and Business Overview
Table 82. Theravance Biopharma Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Theravance Biopharma Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Product
Table 84. Theravance Biopharma Recent Developments/Updates
Table 85. Allergan Corporation Information
Table 86. Allergan Description and Business Overview
Table 87. Allergan Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Allergan Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Product
Table 89. Allergan Recent Developments/Updates
Table 90. Merck & Co., Inc Corporation Information
Table 91. Merck & Co., Inc Description and Business Overview
Table 92. Merck & Co., Inc Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Merck & Co., Inc Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Product
Table 94. Merck & Co., Inc Recent Developments/Updates
Table 95. Pfizer, Inc Corporation Information
Table 96. Pfizer, Inc Description and Business Overview
Table 97. Pfizer, Inc Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Pfizer, Inc Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Product
Table 99. Pfizer, Inc Recent Developments/Updates
Table 100. Key Raw Materials Lists
Table 101. Raw Materials Key Suppliers Lists
Table 102. Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Distributors List
Table 103. Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Customers List
Table 104. Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Trends
Table 105. Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Drivers
Table 106. Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Challenges
Table 107. Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Restraints
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug
Figure 2. Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Share by Type in 2023 & 2030
Figure 4. Lipopeptide Product Picture
Figure 5. Oxazolidinone Product Picture
Figure 6. Tetracycline Product Picture
Figure 7. Cephalosporin Product Picture
Figure 8. Lipoglycopeptide Product Picture
Figure 9. Folate Antagonist Product Picture
Figure 10. Other Product Picture
Figure 11. Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 12. Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Share by Application in 2023 & 2030
Figure 13. Hospital
Figure 14. Specialist Clinic
Figure 15. Other
Figure 16. Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 17. Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Size (2019-2030) & (US$ Million)
Figure 18. Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales (2019-2030) & (K Units)
Figure 19. Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Average Price (US$/Unit) & (2019-2030)
Figure 20. Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Report Years Considered
Figure 21. Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Share by Manufacturers in 2023
Figure 22. Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Revenue Share by Manufacturers in 2023
Figure 23. The Global 5 and 10 Largest Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Players: Market Share by Revenue in 2023
Figure 24. Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 25. Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 26. North America Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Market Share by Country (2019-2030)
Figure 27. North America Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Revenue Market Share by Country (2019-2030)
Figure 28. United States Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Canada Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Europe Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Market Share by Country (2019-2030)
Figure 31. Europe Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Revenue Market Share by Country (2019-2030)
Figure 32. Germany Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. France Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. U.K. Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Italy Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Russia Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Asia Pacific Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Market Share by Region (2019-2030)
Figure 38. Asia Pacific Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Revenue Market Share by Region (2019-2030)
Figure 39. China Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Japan Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. South Korea Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. India Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Australia Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. China Taiwan Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Southeast Asia Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Latin America Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Market Share by Country (2019-2030)
Figure 47. Latin America Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Revenue Market Share by Country (2019-2030)
Figure 48. Mexico Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Brazil Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Argentina Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Middle East & Africa Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Market Share by Country (2019-2030)
Figure 52. Middle East & Africa Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Revenue Market Share by Country (2019-2030)
Figure 53. Turkey Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Saudi Arabia Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. UAE Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. Global Sales Market Share of Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug by Type (2019-2030)
Figure 57. Global Revenue Market Share of Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug by Type (2019-2030)
Figure 58. Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Price (US$/Unit) by Type (2019-2030)
Figure 59. Global Sales Market Share of Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug by Application (2019-2030)
Figure 60. Global Revenue Market Share of Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug by Application (2019-2030)
Figure 61. Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Price (US$/Unit) by Application (2019-2030)
Figure 62. Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Value Chain
Figure 63. Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Distributors Profiles
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed